Pinnacle ICAV - Antipodes Global Fund - Long – UCITS S USD AccRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 12.9 | 10.1 | 0.1 | 10.4 | 7.7 | |
+/-Cat | 11.1 | -8.2 | -0.4 | 1.1 | 1.0 | |
+/-B’mrk | - | -11.2 | -3.5 | 1.7 | -0.5 | |
Category: Global Large-Cap Value Equity | ||||||
Category Benchmark: Morningstar Gbl Val TME NR USD |
Key Stats | ||
NAV 23/04/2024 | USD 13.02 | |
Day Change | 0.35% | |
Morningstar Category™ | Global Large-Cap Value Equity | |
ISIN | IE00BFNKTG02 | |
Fund Size (Mil) 23/04/2024 | USD 148.82 | |
Share Class Size (Mil) 23/04/2024 | USD 69.61 | |
Max Initial Charge | - | |
Ongoing Charge 14/02/2024 | 1.00% |
Investment Objective: Pinnacle ICAV - Antipodes Global Fund - Long – UCITS S USD Acc |
The aim of the Fund is to achieve absolute returns in excess of the MSCI All Country World Net Index in USD (the Index) over the investment cycle (typically 3-5 years). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jacob Mitchell 23/01/2018 | ||
Inception Date 23/01/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Not Benchmarked | Morningstar Gbl Val TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Pinnacle ICAV - Antipodes Global Fund - Long – UCITS S USD Acc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Merck & Co Inc | Healthcare | 3.62 |
Sanofi SA | Healthcare | 3.54 |
Oracle Corp | Technology | 2.95 |
TotalEnergies SE | Energy | 2.89 |
Meta Platforms Inc Class A | Communication Services | 2.78 |
Increase Decrease New since last portfolio | ||
Pinnacle ICAV - Antipodes Global Fund - Long – UCITS S USD Acc |